Tatva Chintan Pharma Chem Limited at its board meeting held on 03 May 2024, recommended a final dividend of INR 2 (20%) per equity share of INR 10 each fully paid (subject to deduction of tax, if any) on the equity share capital of INR 233,920,550 (23,392,055 equity shares of INR 10 each) for the financial year 2023-2024. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,134 INR | +2.04% |
|
+11.13% | -29.21% |
05-03 | Transcript : Tatva Chintan Pharma Chem Limited, Q4 2024 Earnings Call, May 03, 2024 | |
05-03 | Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2023-2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.21% | 315M | |
+21.59% | 68.87B | |
-4.71% | 46.12B | |
+25.80% | 44.85B | |
+32.63% | 27.9B | |
+9.25% | 19.38B | |
+17.02% | 17.2B | |
-13.50% | 14.68B | |
-28.13% | 14.14B | |
-33.19% | 11.49B |
- Stock Market
- Equities
- TATVA Stock
- News Tatva Chintan Pharma Chem Limited
- Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2023-2024